Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV Antibodies | 176 | 2024 | 1300 | 12.980 |
Why?
|
Antibodies, Neutralizing | 182 | 2024 | 1933 | 10.190 |
Why?
|
HIV-1 | 205 | 2024 | 6849 | 8.110 |
Why?
|
AIDS Vaccines | 72 | 2024 | 895 | 5.640 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 65 | 2024 | 368 | 5.240 |
Why?
|
Simian immunodeficiency virus | 46 | 2024 | 805 | 4.250 |
Why?
|
HIV Envelope Protein gp120 | 65 | 2024 | 915 | 3.730 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 35 | 2024 | 538 | 3.400 |
Why?
|
Neutralization Tests | 71 | 2023 | 728 | 3.260 |
Why?
|
HIV Infections | 149 | 2024 | 17165 | 3.220 |
Why?
|
Macaca mulatta | 61 | 2024 | 2316 | 2.020 |
Why?
|
SAIDS Vaccines | 13 | 2022 | 144 | 1.960 |
Why?
|
Gene Products, env | 14 | 2020 | 250 | 1.950 |
Why?
|
Epitopes | 58 | 2024 | 2503 | 1.890 |
Why?
|
Antibodies, Monoclonal | 58 | 2024 | 9185 | 1.740 |
Why?
|
HIV Envelope Protein gp41 | 21 | 2024 | 303 | 1.550 |
Why?
|
Antibodies, Viral | 38 | 2024 | 3143 | 1.550 |
Why?
|
Immunization, Passive | 13 | 2021 | 616 | 1.460 |
Why?
|
Polysaccharides | 25 | 2023 | 1016 | 1.410 |
Why?
|
Vaccines, DNA | 16 | 2024 | 286 | 1.240 |
Why?
|
Viremia | 20 | 2023 | 707 | 1.230 |
Why?
|
Smallpox Vaccine | 7 | 2024 | 77 | 1.210 |
Why?
|
Vaccinia virus | 13 | 2024 | 331 | 1.190 |
Why?
|
Immunization, Secondary | 16 | 2024 | 368 | 1.090 |
Why?
|
Viral Vaccines | 12 | 2020 | 596 | 1.080 |
Why?
|
HIV Antigens | 15 | 2024 | 325 | 1.080 |
Why?
|
Antibodies, Bispecific | 8 | 2023 | 191 | 0.910 |
Why?
|
Viral Load | 32 | 2024 | 3322 | 0.850 |
Why?
|
Respiratory Syncytial Virus Vaccines | 1 | 2022 | 35 | 0.820 |
Why?
|
Antibodies, Anti-Idiotypic | 2 | 2020 | 356 | 0.770 |
Why?
|
CD4-Positive T-Lymphocytes | 25 | 2022 | 4353 | 0.760 |
Why?
|
Binding Sites, Antibody | 12 | 2023 | 337 | 0.760 |
Why?
|
HIV Envelope Protein gp160 | 8 | 2018 | 92 | 0.750 |
Why?
|
Antigens, Viral | 15 | 2023 | 980 | 0.750 |
Why?
|
HIV Seropositivity | 10 | 2024 | 955 | 0.730 |
Why?
|
Virus Internalization | 8 | 2020 | 494 | 0.720 |
Why?
|
Immunoglobulin Fab Fragments | 13 | 2021 | 465 | 0.710 |
Why?
|
Protein Engineering | 12 | 2022 | 541 | 0.700 |
Why?
|
Vaccination | 21 | 2024 | 3361 | 0.680 |
Why?
|
Immunoglobulin A | 8 | 2022 | 979 | 0.670 |
Why?
|
Cross Reactions | 17 | 2021 | 818 | 0.670 |
Why?
|
B-Lymphocytes | 22 | 2024 | 4742 | 0.670 |
Why?
|
Antibody Formation | 16 | 2020 | 1400 | 0.640 |
Why?
|
Immunoglobulin G | 23 | 2023 | 4541 | 0.620 |
Why?
|
Immunologic Memory | 10 | 2014 | 1354 | 0.610 |
Why?
|
Animals | 149 | 2024 | 167963 | 0.580 |
Why?
|
Anti-Retroviral Agents | 9 | 2024 | 1779 | 0.580 |
Why?
|
Antibody Specificity | 16 | 2019 | 1060 | 0.560 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2020 | 693 | 0.550 |
Why?
|
HIV | 7 | 2020 | 1579 | 0.550 |
Why?
|
T-Lymphocytes, Cytotoxic | 7 | 2009 | 1765 | 0.540 |
Why?
|
Papillomavirus Vaccines | 1 | 2022 | 495 | 0.530 |
Why?
|
Antibody Affinity | 10 | 2022 | 245 | 0.510 |
Why?
|
Immunity, Cellular | 12 | 2021 | 1557 | 0.510 |
Why?
|
Influenza Vaccines | 1 | 2022 | 766 | 0.490 |
Why?
|
Immunization | 12 | 2021 | 1227 | 0.490 |
Why?
|
Adenoviridae | 11 | 2018 | 1084 | 0.490 |
Why?
|
Models, Molecular | 24 | 2022 | 5434 | 0.490 |
Why?
|
Viral Envelope Proteins | 6 | 2014 | 638 | 0.480 |
Why?
|
Genetic Vectors | 14 | 2023 | 3380 | 0.470 |
Why?
|
Adenoviruses, Human | 6 | 2014 | 255 | 0.460 |
Why?
|
Binding Sites | 23 | 2024 | 6048 | 0.460 |
Why?
|
HEK293 Cells | 25 | 2021 | 4264 | 0.460 |
Why?
|
Membrane Fusion | 4 | 2021 | 266 | 0.430 |
Why?
|
Amino Acid Sequence | 34 | 2019 | 13451 | 0.430 |
Why?
|
Epitopes, B-Lymphocyte | 2 | 2012 | 81 | 0.410 |
Why?
|
Protein Conformation | 19 | 2022 | 3969 | 0.400 |
Why?
|
Humans | 217 | 2024 | 760621 | 0.390 |
Why?
|
Antiviral Agents | 7 | 2022 | 3061 | 0.380 |
Why?
|
Virus Replication | 8 | 2023 | 2432 | 0.370 |
Why?
|
CD8-Positive T-Lymphocytes | 15 | 2024 | 4550 | 0.360 |
Why?
|
Camelids, New World | 3 | 2014 | 20 | 0.340 |
Why?
|
Evolution, Molecular | 5 | 2015 | 1885 | 0.340 |
Why?
|
Inhibitory Concentration 50 | 9 | 2019 | 465 | 0.330 |
Why?
|
H-2 Antigens | 2 | 2000 | 358 | 0.330 |
Why?
|
Vaccines, Synthetic | 9 | 2018 | 617 | 0.330 |
Why?
|
Immune Evasion | 3 | 2021 | 362 | 0.330 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 6 | 2023 | 303 | 0.330 |
Why?
|
Milk, Human | 2 | 2011 | 483 | 0.330 |
Why?
|
Cryoelectron Microscopy | 9 | 2024 | 642 | 0.320 |
Why?
|
Complementarity Determining Regions | 7 | 2024 | 149 | 0.320 |
Why?
|
Virion | 4 | 2018 | 421 | 0.310 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 21 | 2016 | 3804 | 0.310 |
Why?
|
Immunotherapy | 8 | 2024 | 4642 | 0.310 |
Why?
|
Crystallography, X-Ray | 14 | 2021 | 1982 | 0.310 |
Why?
|
Vaccines | 4 | 2023 | 832 | 0.310 |
Why?
|
Peptide Fragments | 11 | 2021 | 5125 | 0.310 |
Why?
|
Protein Multimerization | 10 | 2021 | 983 | 0.300 |
Why?
|
Anti-HIV Agents | 9 | 2022 | 4491 | 0.300 |
Why?
|
Immunity, Humoral | 8 | 2021 | 604 | 0.300 |
Why?
|
Adjuvants, Immunologic | 5 | 2020 | 1039 | 0.290 |
Why?
|
Molecular Sequence Data | 29 | 2015 | 17624 | 0.290 |
Why?
|
Lymphocyte Activation | 10 | 2020 | 5496 | 0.290 |
Why?
|
Epitope Mapping | 7 | 2020 | 297 | 0.280 |
Why?
|
Histocompatibility Antigens Class I | 6 | 2015 | 1355 | 0.270 |
Why?
|
Guinea Pigs | 10 | 2020 | 1316 | 0.270 |
Why?
|
RNA, Viral | 10 | 2020 | 2838 | 0.270 |
Why?
|
Virus Latency | 3 | 2022 | 362 | 0.260 |
Why?
|
Protein Binding | 19 | 2023 | 9335 | 0.260 |
Why?
|
Mutation | 29 | 2024 | 29932 | 0.260 |
Why?
|
Injections, Intramuscular | 8 | 2020 | 553 | 0.250 |
Why?
|
Glycosylation | 9 | 2021 | 1096 | 0.250 |
Why?
|
Immunoglobulin Variable Region | 6 | 2021 | 419 | 0.250 |
Why?
|
Primates | 4 | 2021 | 523 | 0.240 |
Why?
|
Listeriosis | 3 | 2000 | 148 | 0.240 |
Why?
|
Recombinant Proteins | 16 | 2021 | 6538 | 0.240 |
Why?
|
Food Contamination | 1 | 2006 | 192 | 0.240 |
Why?
|
Rabbits | 13 | 2023 | 4773 | 0.240 |
Why?
|
Leukocytes, Mononuclear | 9 | 2019 | 1827 | 0.240 |
Why?
|
Cell Line | 22 | 2021 | 15620 | 0.240 |
Why?
|
Epitopes, T-Lymphocyte | 9 | 2018 | 824 | 0.230 |
Why?
|
Mice | 43 | 2024 | 81208 | 0.230 |
Why?
|
Phylogeny | 12 | 2022 | 2775 | 0.220 |
Why?
|
Monkeypox virus | 1 | 2023 | 42 | 0.220 |
Why?
|
Immunoglobulin Heavy Chains | 6 | 2019 | 649 | 0.220 |
Why?
|
Double-Blind Method | 16 | 2024 | 12427 | 0.220 |
Why?
|
Immunoglobulin Fc Fragments | 3 | 2021 | 280 | 0.220 |
Why?
|
Surface Plasmon Resonance | 8 | 2020 | 265 | 0.210 |
Why?
|
Listeria monocytogenes | 3 | 2000 | 248 | 0.210 |
Why?
|
Animals, Wild | 1 | 2023 | 77 | 0.210 |
Why?
|
Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2022 | 52 | 0.210 |
Why?
|
Epidemics | 2 | 2021 | 510 | 0.200 |
Why?
|
Convalescence | 1 | 2022 | 106 | 0.200 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 2022 | 72 | 0.200 |
Why?
|
Genotype | 3 | 2015 | 12960 | 0.200 |
Why?
|
Vaccinia | 2 | 2013 | 71 | 0.200 |
Why?
|
Mucous Membrane | 3 | 2018 | 657 | 0.200 |
Why?
|
Immunity, Mucosal | 4 | 2014 | 482 | 0.200 |
Why?
|
Disease Reservoirs | 2 | 2019 | 121 | 0.200 |
Why?
|
Macaca | 6 | 2022 | 409 | 0.190 |
Why?
|
Gene Products, gag | 5 | 2020 | 312 | 0.190 |
Why?
|
Interleukin-12 | 1 | 2004 | 584 | 0.190 |
Why?
|
Receptors, Virus | 3 | 2021 | 639 | 0.180 |
Why?
|
Single-Chain Antibodies | 2 | 2019 | 111 | 0.180 |
Why?
|
Recombination, Genetic | 3 | 2018 | 1526 | 0.180 |
Why?
|
Commerce | 1 | 2006 | 605 | 0.180 |
Why?
|
Hinge Exons | 1 | 2020 | 2 | 0.180 |
Why?
|
Female | 74 | 2024 | 391270 | 0.180 |
Why?
|
Receptors, Antigen, B-Cell | 3 | 2021 | 545 | 0.180 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2020 | 111 | 0.180 |
Why?
|
Vaccines, Attenuated | 5 | 2016 | 314 | 0.180 |
Why?
|
Clone Cells | 4 | 2019 | 1660 | 0.170 |
Why?
|
Male | 60 | 2024 | 359744 | 0.170 |
Why?
|
Protein Structure, Tertiary | 10 | 2018 | 3800 | 0.170 |
Why?
|
Receptors, HIV | 4 | 2013 | 159 | 0.170 |
Why?
|
Immunoglobulin Light Chains | 3 | 2016 | 286 | 0.170 |
Why?
|
Dose-Response Relationship, Immunologic | 4 | 2018 | 365 | 0.170 |
Why?
|
Drug Users | 1 | 2021 | 132 | 0.170 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2021 | 326 | 0.170 |
Why?
|
BCG Vaccine | 1 | 2022 | 371 | 0.170 |
Why?
|
T-Lymphocytes | 13 | 2019 | 10181 | 0.170 |
Why?
|
Vaccines, Inactivated | 1 | 2020 | 180 | 0.170 |
Why?
|
Mannose | 2 | 2016 | 121 | 0.160 |
Why?
|
DNA Primers | 3 | 2016 | 2819 | 0.160 |
Why?
|
Proviruses | 4 | 2023 | 313 | 0.160 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 165 | 0.160 |
Why?
|
Acquired Immunodeficiency Syndrome | 3 | 2013 | 2197 | 0.160 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2017 | 1446 | 0.160 |
Why?
|
Mutant Proteins | 4 | 2015 | 492 | 0.160 |
Why?
|
Antigen-Antibody Complex | 3 | 2021 | 513 | 0.160 |
Why?
|
Receptors, Fc | 3 | 2017 | 534 | 0.160 |
Why?
|
Luminescent Measurements | 1 | 2020 | 378 | 0.150 |
Why?
|
Drug Carriers | 3 | 2018 | 709 | 0.150 |
Why?
|
Biological Clocks | 1 | 2020 | 316 | 0.150 |
Why?
|
Sequence Alignment | 7 | 2020 | 2176 | 0.150 |
Why?
|
Disease Models, Animal | 15 | 2020 | 18137 | 0.150 |
Why?
|
Vaccines, Subunit | 4 | 2024 | 161 | 0.150 |
Why?
|
T-Lymphocyte Subsets | 5 | 2018 | 1810 | 0.150 |
Why?
|
Half-Life | 4 | 2022 | 652 | 0.150 |
Why?
|
Antigens | 3 | 2017 | 1447 | 0.140 |
Why?
|
Gene Knock-In Techniques | 2 | 2016 | 419 | 0.140 |
Why?
|
Immunocompromised Host | 2 | 2020 | 857 | 0.140 |
Why?
|
Immunodominant Epitopes | 3 | 2019 | 241 | 0.140 |
Why?
|
Macaca fascicularis | 4 | 2020 | 900 | 0.140 |
Why?
|
HLA-B27 Antigen | 1 | 2017 | 63 | 0.140 |
Why?
|
Recombinant Fusion Proteins | 2 | 2024 | 3735 | 0.140 |
Why?
|
Vaccines, Virus-Like Particle | 1 | 2017 | 45 | 0.140 |
Why?
|
Sexually Transmitted Diseases | 1 | 2022 | 628 | 0.140 |
Why?
|
Injections, Intradermal | 3 | 2014 | 116 | 0.140 |
Why?
|
Toll-Like Receptor 7 | 1 | 2018 | 177 | 0.140 |
Why?
|
Substance Abuse, Intravenous | 1 | 2021 | 530 | 0.140 |
Why?
|
Antigen-Antibody Reactions | 2 | 2021 | 346 | 0.140 |
Why?
|
Disease Outbreaks | 1 | 2006 | 1758 | 0.140 |
Why?
|
Receptors, CCR5 | 3 | 2015 | 488 | 0.130 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2020 | 599 | 0.130 |
Why?
|
Young Adult | 22 | 2024 | 58741 | 0.130 |
Why?
|
Lymphocytic choriomeningitis virus | 1 | 2016 | 177 | 0.130 |
Why?
|
HLA-B Antigens | 1 | 2017 | 331 | 0.130 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2016 | 99 | 0.130 |
Why?
|
Protein Stability | 4 | 2019 | 566 | 0.120 |
Why?
|
Transduction, Genetic | 1 | 2018 | 897 | 0.120 |
Why?
|
Models, Animal | 1 | 2021 | 2117 | 0.120 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 4 | 2020 | 400 | 0.120 |
Why?
|
Adult | 34 | 2024 | 219994 | 0.120 |
Why?
|
CD4 Lymphocyte Count | 8 | 2017 | 2569 | 0.120 |
Why?
|
Gene Expression | 4 | 2019 | 7588 | 0.120 |
Why?
|
Polyvinyls | 2 | 2012 | 154 | 0.120 |
Why?
|
Lymphocyte Depletion | 1 | 2016 | 602 | 0.110 |
Why?
|
Phagocytosis | 1 | 2020 | 1535 | 0.110 |
Why?
|
Fetal Blood | 1 | 2020 | 1343 | 0.110 |
Why?
|
Cochlea | 1 | 2020 | 844 | 0.110 |
Why?
|
Skin Absorption | 1 | 2013 | 94 | 0.110 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2020 | 1348 | 0.110 |
Why?
|
CD4 Immunoadhesins | 1 | 2013 | 12 | 0.110 |
Why?
|
Fowlpox virus | 2 | 2012 | 21 | 0.110 |
Why?
|
Antibodies | 3 | 2023 | 2421 | 0.110 |
Why?
|
Serum | 1 | 2014 | 211 | 0.110 |
Why?
|
Virulence | 4 | 2017 | 1298 | 0.110 |
Why?
|
Orthopoxvirus | 1 | 2012 | 11 | 0.110 |
Why?
|
Microinjections | 1 | 2013 | 321 | 0.110 |
Why?
|
Hearing Loss | 1 | 2020 | 780 | 0.100 |
Why?
|
Dependovirus | 2 | 2015 | 709 | 0.100 |
Why?
|
Drug Design | 3 | 2013 | 1061 | 0.100 |
Why?
|
Antithrombin III | 1 | 2012 | 129 | 0.100 |
Why?
|
Epithelium | 1 | 2017 | 1605 | 0.100 |
Why?
|
Squalene | 1 | 2012 | 35 | 0.100 |
Why?
|
Gene Products, pol | 3 | 2020 | 43 | 0.100 |
Why?
|
Polysorbates | 1 | 2012 | 43 | 0.100 |
Why?
|
Forecasting | 1 | 2021 | 2932 | 0.100 |
Why?
|
Structure-Activity Relationship | 4 | 2022 | 3084 | 0.100 |
Why?
|
DNA, Viral | 4 | 2013 | 2194 | 0.100 |
Why?
|
Immunoglobulins | 1 | 2015 | 859 | 0.100 |
Why?
|
Placenta | 1 | 2020 | 1702 | 0.100 |
Why?
|
Poxviridae | 3 | 2019 | 37 | 0.100 |
Why?
|
Amino Acid Substitution | 4 | 2021 | 1737 | 0.090 |
Why?
|
Cancer Vaccines | 2 | 2017 | 1046 | 0.090 |
Why?
|
Middle Aged | 27 | 2024 | 220352 | 0.090 |
Why?
|
Adenoviridae Infections | 1 | 2011 | 93 | 0.090 |
Why?
|
Capsid Proteins | 1 | 2014 | 467 | 0.090 |
Why?
|
Needles | 1 | 2013 | 451 | 0.090 |
Why?
|
High-Throughput Screening Assays | 2 | 2013 | 944 | 0.090 |
Why?
|
Administration, Intravaginal | 3 | 2020 | 151 | 0.090 |
Why?
|
Kinetics | 5 | 2024 | 6377 | 0.090 |
Why?
|
Plasma | 2 | 2011 | 584 | 0.090 |
Why?
|
Plasmids | 5 | 2011 | 2275 | 0.090 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2004 | 3075 | 0.090 |
Why?
|
Delayed-Action Preparations | 1 | 2013 | 961 | 0.090 |
Why?
|
Adenoviruses, Simian | 1 | 2009 | 15 | 0.090 |
Why?
|
Intestinal Mucosa | 3 | 2017 | 3022 | 0.080 |
Why?
|
Placebos | 3 | 2021 | 1668 | 0.080 |
Why?
|
Virus Shedding | 1 | 2010 | 111 | 0.080 |
Why?
|
Mice, Inbred BALB C | 7 | 2018 | 6216 | 0.080 |
Why?
|
Computational Biology | 4 | 2018 | 3505 | 0.080 |
Why?
|
Cricetulus | 3 | 2020 | 815 | 0.080 |
Why?
|
Protein Structure, Quaternary | 3 | 2021 | 428 | 0.080 |
Why?
|
Antigens, Neoplasm | 1 | 2017 | 1998 | 0.080 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 3 | 2016 | 206 | 0.080 |
Why?
|
Time Factors | 11 | 2020 | 40165 | 0.080 |
Why?
|
Defective Viruses | 1 | 2009 | 89 | 0.080 |
Why?
|
Mammary Glands, Animal | 1 | 2010 | 271 | 0.080 |
Why?
|
Cells, Cultured | 8 | 2023 | 18957 | 0.080 |
Why?
|
HeLa Cells | 4 | 2020 | 3105 | 0.080 |
Why?
|
Immunization Schedule | 2 | 2020 | 224 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 2125 | 0.080 |
Why?
|
CHO Cells | 3 | 2020 | 1389 | 0.080 |
Why?
|
Cloning, Molecular | 4 | 2019 | 4169 | 0.080 |
Why?
|
Lactation | 1 | 2010 | 397 | 0.080 |
Why?
|
Smallpox | 1 | 2008 | 43 | 0.080 |
Why?
|
Cytotoxicity, Immunologic | 4 | 2000 | 1351 | 0.080 |
Why?
|
Magnetic Resonance Spectroscopy | 4 | 2020 | 3765 | 0.080 |
Why?
|
Cholera Toxin | 1 | 2010 | 559 | 0.070 |
Why?
|
Protein Subunits | 2 | 2021 | 943 | 0.070 |
Why?
|
Mice, Inbred NOD | 3 | 2020 | 1837 | 0.070 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2021 | 1894 | 0.070 |
Why?
|
Killer Cells, Natural | 2 | 2011 | 2203 | 0.070 |
Why?
|
Conserved Sequence | 3 | 2018 | 1167 | 0.070 |
Why?
|
Mutagenesis, Site-Directed | 3 | 2018 | 1693 | 0.070 |
Why?
|
Escherichia coli | 1 | 2019 | 4219 | 0.070 |
Why?
|
Drug Evaluation, Preclinical | 3 | 2020 | 1347 | 0.070 |
Why?
|
Amino Acids | 2 | 2024 | 1714 | 0.070 |
Why?
|
Protein Array Analysis | 1 | 2009 | 401 | 0.070 |
Why?
|
Transcytosis | 2 | 2017 | 45 | 0.070 |
Why?
|
Classical Swine Fever | 1 | 2006 | 1 | 0.070 |
Why?
|
Swine Vesicular Disease | 1 | 2006 | 1 | 0.070 |
Why?
|
Foot-and-Mouth Disease | 1 | 2006 | 7 | 0.070 |
Why?
|
Mice, Transgenic | 5 | 2019 | 9530 | 0.070 |
Why?
|
Mice, Knockout | 6 | 2018 | 14372 | 0.070 |
Why?
|
African Swine Fever | 1 | 2006 | 7 | 0.070 |
Why?
|
Membrane Glycoproteins | 5 | 2012 | 3707 | 0.070 |
Why?
|
Injections | 2 | 2020 | 830 | 0.070 |
Why?
|
Swine Diseases | 1 | 2006 | 62 | 0.070 |
Why?
|
Drug Resistance, Viral | 3 | 2018 | 859 | 0.060 |
Why?
|
Cytotoxicity Tests, Immunologic | 2 | 2004 | 321 | 0.060 |
Why?
|
Dimerization | 2 | 2021 | 891 | 0.060 |
Why?
|
Hepacivirus | 1 | 2012 | 1334 | 0.060 |
Why?
|
Lipid Bilayers | 2 | 2018 | 383 | 0.060 |
Why?
|
Immunoconjugates | 1 | 2013 | 949 | 0.060 |
Why?
|
Drug Therapy, Combination | 3 | 2024 | 6498 | 0.060 |
Why?
|
Polymerase Chain Reaction | 3 | 2017 | 6068 | 0.060 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2014 | 2753 | 0.060 |
Why?
|
Adoptive Transfer | 2 | 2019 | 822 | 0.060 |
Why?
|
Adolescent | 12 | 2024 | 87810 | 0.060 |
Why?
|
Epithelial Cells | 1 | 2016 | 3663 | 0.060 |
Why?
|
Risk Assessment | 1 | 2006 | 24123 | 0.060 |
Why?
|
Enzyme-Linked Immunospot Assay | 2 | 2015 | 123 | 0.060 |
Why?
|
Spleen | 4 | 2015 | 2298 | 0.060 |
Why?
|
Amino Acid Motifs | 2 | 2019 | 929 | 0.060 |
Why?
|
Flow Cytometry | 5 | 2020 | 5870 | 0.060 |
Why?
|
Proteolipids | 2 | 2014 | 113 | 0.060 |
Why?
|
HIV Fusion Inhibitors | 2 | 2014 | 82 | 0.060 |
Why?
|
Vagina | 3 | 2020 | 837 | 0.050 |
Why?
|
Molecular Dynamics Simulation | 2 | 2018 | 435 | 0.050 |
Why?
|
Meat | 1 | 2006 | 584 | 0.050 |
Why?
|
Consensus Sequence | 2 | 2015 | 365 | 0.050 |
Why?
|
DNA | 1 | 2016 | 7233 | 0.050 |
Why?
|
Protein Structure, Secondary | 2 | 2019 | 1229 | 0.050 |
Why?
|
Antigens, Bacterial | 2 | 2016 | 1155 | 0.050 |
Why?
|
Chromatography, Gel | 2 | 2013 | 645 | 0.050 |
Why?
|
Peptide Library | 2 | 2014 | 347 | 0.050 |
Why?
|
Cytokines | 6 | 2017 | 7343 | 0.050 |
Why?
|
Transcription, Genetic | 2 | 2014 | 7593 | 0.050 |
Why?
|
Interferon-gamma | 4 | 2016 | 3157 | 0.050 |
Why?
|
Antibodies, Heterophile | 1 | 2021 | 128 | 0.050 |
Why?
|
Base Sequence | 4 | 2017 | 12446 | 0.050 |
Why?
|
Acrylic Resins | 2 | 2012 | 135 | 0.050 |
Why?
|
Cell Separation | 2 | 2017 | 1720 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8624 | 0.050 |
Why?
|
Cross-Linking Reagents | 2 | 2015 | 685 | 0.050 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 2 | 2011 | 57 | 0.050 |
Why?
|
Bayes Theorem | 2 | 2019 | 2326 | 0.050 |
Why?
|
HLA-D Antigens | 1 | 2000 | 134 | 0.050 |
Why?
|
Molecular Mimicry | 2 | 2011 | 200 | 0.040 |
Why?
|
Dequalinium | 1 | 2020 | 7 | 0.040 |
Why?
|
Liposomes | 1 | 2024 | 777 | 0.040 |
Why?
|
HIV Protease | 2 | 2010 | 97 | 0.040 |
Why?
|
Vesiculovirus | 1 | 2020 | 54 | 0.040 |
Why?
|
Serine Endopeptidases | 2 | 2020 | 1021 | 0.040 |
Why?
|
Fluorescence Polarization | 1 | 2020 | 140 | 0.040 |
Why?
|
Cell Fusion | 1 | 2020 | 293 | 0.040 |
Why?
|
Haplorhini | 2 | 2011 | 529 | 0.040 |
Why?
|
Sequence Analysis | 1 | 2020 | 240 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 2022 | 623 | 0.040 |
Why?
|
Mice, Inbred C57BL | 6 | 2016 | 22023 | 0.040 |
Why?
|
Electrochemical Techniques | 1 | 2020 | 95 | 0.040 |
Why?
|
Penis | 1 | 2020 | 212 | 0.040 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 1999 | 1854 | 0.040 |
Why?
|
Cohort Studies | 6 | 2020 | 41335 | 0.040 |
Why?
|
Immunity, Innate | 1 | 2011 | 3047 | 0.040 |
Why?
|
Cross-Priming | 1 | 2019 | 75 | 0.040 |
Why?
|
Melanoma | 2 | 2017 | 5697 | 0.040 |
Why?
|
Point Mutation | 2 | 2018 | 1594 | 0.040 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2021 | 453 | 0.040 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 1 | 2019 | 101 | 0.040 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 1 | 2020 | 253 | 0.040 |
Why?
|
Organoplatinum Compounds | 1 | 2020 | 410 | 0.040 |
Why?
|
Immune Sera | 2 | 2014 | 613 | 0.040 |
Why?
|
Bioreactors | 1 | 2019 | 244 | 0.040 |
Why?
|
Pteridines | 1 | 2018 | 47 | 0.040 |
Why?
|
Antigens, Ly | 1 | 1999 | 292 | 0.040 |
Why?
|
Remission Induction | 1 | 2024 | 2392 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2019 | 266 | 0.040 |
Why?
|
Animals, Genetically Modified | 1 | 2023 | 1553 | 0.040 |
Why?
|
Cell Membrane | 2 | 2020 | 3682 | 0.040 |
Why?
|
Peptides | 5 | 2009 | 4354 | 0.040 |
Why?
|
Drug Compounding | 1 | 2018 | 246 | 0.040 |
Why?
|
Inflammation | 1 | 2017 | 10756 | 0.040 |
Why?
|
Crystallization | 1 | 2018 | 533 | 0.040 |
Why?
|
Software | 1 | 2011 | 4419 | 0.040 |
Why?
|
Influenza A virus | 1 | 2020 | 457 | 0.040 |
Why?
|
Transfection | 3 | 2013 | 5781 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 1999 | 780 | 0.030 |
Why?
|
Receptors, Interferon | 1 | 2017 | 116 | 0.030 |
Why?
|
Cell Adhesion Molecules | 1 | 2023 | 1602 | 0.030 |
Why?
|
Solubility | 1 | 2018 | 1088 | 0.030 |
Why?
|
Virus Activation | 1 | 2018 | 319 | 0.030 |
Why?
|
Thermodynamics | 1 | 2018 | 599 | 0.030 |
Why?
|
Liver | 4 | 2011 | 7509 | 0.030 |
Why?
|
Antigen Presentation | 2 | 1999 | 1254 | 0.030 |
Why?
|
Reference Standards | 1 | 2020 | 1004 | 0.030 |
Why?
|
Antigens, CD | 2 | 1999 | 4000 | 0.030 |
Why?
|
Africa, Eastern | 1 | 2016 | 76 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2019 | 5785 | 0.030 |
Why?
|
Swine | 1 | 2006 | 5899 | 0.030 |
Why?
|
Sequence Analysis, DNA | 3 | 2013 | 4713 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 1999 | 587 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1832 | 0.030 |
Why?
|
Mannosidases | 1 | 2015 | 21 | 0.030 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 1997 | 412 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2020 | 1529 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2000 | 1871 | 0.030 |
Why?
|
Molecular Structure | 1 | 2020 | 1895 | 0.030 |
Why?
|
Homosexuality, Male | 1 | 2023 | 1273 | 0.030 |
Why?
|
New York | 1 | 2018 | 875 | 0.030 |
Why?
|
Carrier Proteins | 2 | 2023 | 4938 | 0.030 |
Why?
|
Placebo Effect | 1 | 2019 | 520 | 0.030 |
Why?
|
Cluster Analysis | 2 | 2013 | 2698 | 0.030 |
Why?
|
Cell Lineage | 1 | 2024 | 2533 | 0.030 |
Why?
|
Neutron Diffraction | 1 | 2014 | 10 | 0.030 |
Why?
|
Host-Pathogen Interactions | 2 | 2014 | 1447 | 0.030 |
Why?
|
Treatment Outcome | 6 | 2018 | 65017 | 0.030 |
Why?
|
Carrier State | 1 | 2018 | 525 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2013 | 5649 | 0.030 |
Why?
|
Glycoproteins | 1 | 2022 | 2208 | 0.030 |
Why?
|
Antigens, Surface | 2 | 1999 | 1608 | 0.030 |
Why?
|
Proteins | 2 | 1999 | 6029 | 0.030 |
Why?
|
Scattering, Small Angle | 1 | 2014 | 64 | 0.030 |
Why?
|
HIV-2 | 1 | 2015 | 156 | 0.030 |
Why?
|
Small Molecule Libraries | 1 | 2020 | 734 | 0.030 |
Why?
|
Systems Biology | 1 | 2018 | 482 | 0.030 |
Why?
|
Hybridomas | 1 | 2015 | 442 | 0.030 |
Why?
|
Autoantigens | 1 | 2018 | 877 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2020 | 20080 | 0.030 |
Why?
|
Human Immunodeficiency Virus Proteins | 1 | 2013 | 59 | 0.030 |
Why?
|
Electron Spin Resonance Spectroscopy | 1 | 2013 | 162 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 2234 | 0.030 |
Why?
|
Alleles | 3 | 2011 | 6898 | 0.030 |
Why?
|
Aspartate Aminotransferases | 1 | 2015 | 416 | 0.030 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2013 | 220 | 0.030 |
Why?
|
Microscopy, Electron | 1 | 2017 | 2558 | 0.030 |
Why?
|
Molecular Conformation | 1 | 2014 | 548 | 0.030 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2016 | 511 | 0.030 |
Why?
|
Dendritic Cells | 1 | 2004 | 2725 | 0.030 |
Why?
|
Diketopiperazines | 1 | 2013 | 24 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 3 | 2009 | 801 | 0.030 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 1994 | 317 | 0.030 |
Why?
|
Automation, Laboratory | 1 | 2013 | 103 | 0.030 |
Why?
|
Viral Tropism | 1 | 2013 | 102 | 0.030 |
Why?
|
Trifluoroethanol | 1 | 1992 | 3 | 0.030 |
Why?
|
Cameroon | 1 | 2013 | 74 | 0.030 |
Why?
|
Germinal Center | 1 | 2016 | 379 | 0.030 |
Why?
|
Chick Embryo | 1 | 2015 | 981 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2005 | 0.030 |
Why?
|
Interferon Type I | 1 | 2017 | 559 | 0.030 |
Why?
|
Spiro Compounds | 1 | 2013 | 68 | 0.030 |
Why?
|
Limit of Detection | 1 | 2013 | 280 | 0.030 |
Why?
|
Probability | 1 | 2018 | 2475 | 0.030 |
Why?
|
Electroporation | 1 | 2014 | 255 | 0.030 |
Why?
|
Arginine | 1 | 2016 | 934 | 0.030 |
Why?
|
Drug Combinations | 1 | 2018 | 2025 | 0.030 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2014 | 438 | 0.030 |
Why?
|
Genetic Variation | 3 | 2014 | 6551 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2018 | 2222 | 0.030 |
Why?
|
Ultracentrifugation | 1 | 2012 | 183 | 0.030 |
Why?
|
Geography | 1 | 2014 | 661 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2016 | 2262 | 0.030 |
Why?
|
Freund's Adjuvant | 1 | 2012 | 149 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 1994 | 345 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2018 | 14495 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 1999 | 2105 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2020 | 2440 | 0.020 |
Why?
|
Autophagy | 1 | 1999 | 1337 | 0.020 |
Why?
|
Hydroxamic Acids | 1 | 2014 | 482 | 0.020 |
Why?
|
Administration, Cutaneous | 1 | 2013 | 713 | 0.020 |
Why?
|
Benzoates | 1 | 2013 | 212 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2021 | 9411 | 0.020 |
Why?
|
Receptors, IgG | 1 | 2014 | 559 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2013 | 848 | 0.020 |
Why?
|
Quality Control | 1 | 2013 | 828 | 0.020 |
Why?
|
Genes, Immunoglobulin Light Chain | 1 | 2010 | 2 | 0.020 |
Why?
|
Protein Folding | 1 | 2014 | 867 | 0.020 |
Why?
|
Cardiolipins | 1 | 2010 | 81 | 0.020 |
Why?
|
Cytoplasm | 1 | 2015 | 1516 | 0.020 |
Why?
|
Molecular Typing | 1 | 2011 | 116 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 2 | 1999 | 2698 | 0.020 |
Why?
|
South Africa | 1 | 2016 | 1821 | 0.020 |
Why?
|
DNA, Recombinant | 1 | 2010 | 455 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2020 | 22053 | 0.020 |
Why?
|
London | 1 | 2010 | 234 | 0.020 |
Why?
|
Lymphocyte Subsets | 1 | 2011 | 310 | 0.020 |
Why?
|
Immune Tolerance | 1 | 1999 | 2299 | 0.020 |
Why?
|
Interleukin-4 | 1 | 1994 | 1130 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 1999 | 2828 | 0.020 |
Why?
|
Rectum | 1 | 2014 | 895 | 0.020 |
Why?
|
HIV Reverse Transcriptase | 1 | 2010 | 212 | 0.020 |
Why?
|
Th1 Cells | 1 | 1994 | 1032 | 0.020 |
Why?
|
Th2 Cells | 1 | 1994 | 1047 | 0.020 |
Why?
|
Databases as Topic | 1 | 2011 | 474 | 0.020 |
Why?
|
Ligands | 2 | 2012 | 3276 | 0.020 |
Why?
|
Pan troglodytes | 1 | 2009 | 224 | 0.020 |
Why?
|
Viral Structural Proteins | 1 | 2009 | 95 | 0.020 |
Why?
|
Genome, Viral | 1 | 2012 | 658 | 0.020 |
Why?
|
Ectromelia virus | 1 | 2008 | 5 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2010 | 680 | 0.020 |
Why?
|
Biotinylation | 1 | 2008 | 184 | 0.020 |
Why?
|
Models, Biological | 2 | 2018 | 9467 | 0.020 |
Why?
|
United States | 3 | 2024 | 72461 | 0.020 |
Why?
|
Aged | 5 | 2018 | 169152 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 4899 | 0.020 |
Why?
|
Prospective Studies | 2 | 2024 | 54303 | 0.020 |
Why?
|
Observer Variation | 1 | 2013 | 2601 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2009 | 697 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2013 | 15289 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14660 | 0.020 |
Why?
|
Colon | 1 | 2014 | 1788 | 0.020 |
Why?
|
India | 1 | 2013 | 2336 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2008 | 1744 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2007 | 1055 | 0.020 |
Why?
|
Logistic Models | 2 | 2011 | 13314 | 0.020 |
Why?
|
Area Under Curve | 1 | 2010 | 1636 | 0.020 |
Why?
|
Blotting, Western | 1 | 2013 | 5039 | 0.020 |
Why?
|
Chemoprevention | 1 | 2008 | 326 | 0.020 |
Why?
|
Adenovirus E1 Proteins | 1 | 2005 | 6 | 0.020 |
Why?
|
Adenovirus E3 Proteins | 1 | 2005 | 7 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 1994 | 4357 | 0.020 |
Why?
|
Information Storage and Retrieval | 1 | 2011 | 822 | 0.020 |
Why?
|
Equipment Design | 1 | 2013 | 3520 | 0.020 |
Why?
|
Immunoglobulin Class Switching | 1 | 2007 | 289 | 0.020 |
Why?
|
Macrophages | 1 | 2020 | 5745 | 0.020 |
Why?
|
Chemokine CCL3 | 1 | 2004 | 84 | 0.020 |
Why?
|
Fusion Proteins, gag-pol | 1 | 2004 | 7 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8552 | 0.020 |
Why?
|
Chemokine CCL4 | 1 | 2004 | 126 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 3616 | 0.020 |
Why?
|
Macrophage Inflammatory Proteins | 1 | 2004 | 121 | 0.020 |
Why?
|
Herpesvirus 4, Human | 1 | 2010 | 1075 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2011 | 2362 | 0.010 |
Why?
|
Cell Division | 2 | 1994 | 4463 | 0.010 |
Why?
|
Granzymes | 1 | 2006 | 276 | 0.010 |
Why?
|
Gene Products, nef | 1 | 2004 | 100 | 0.010 |
Why?
|
Cell Differentiation | 2 | 2018 | 11481 | 0.010 |
Why?
|
Algorithms | 2 | 2018 | 13981 | 0.010 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 1 | 2004 | 148 | 0.010 |
Why?
|
Immune System | 1 | 2009 | 798 | 0.010 |
Why?
|
Cricetinae | 1 | 2007 | 2427 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10446 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2013 | 2283 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1987 | 2502 | 0.010 |
Why?
|
Information Dissemination | 1 | 2011 | 1131 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15840 | 0.010 |
Why?
|
Interleukin-2 | 2 | 2003 | 1889 | 0.010 |
Why?
|
Piperazines | 1 | 2013 | 2525 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2010 | 4107 | 0.010 |
Why?
|
Tumor Cells, Cultured | 2 | 1999 | 6131 | 0.010 |
Why?
|
Gene Expression Regulation | 2 | 2012 | 11903 | 0.010 |
Why?
|
Chemotaxis | 1 | 2004 | 598 | 0.010 |
Why?
|
Species Specificity | 1 | 2005 | 2418 | 0.010 |
Why?
|
Pregnancy | 2 | 2020 | 29749 | 0.010 |
Why?
|
Viral Proteins | 1 | 2008 | 1802 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26181 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 8056 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2010 | 2696 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2017 | 8950 | 0.010 |
Why?
|
Receptors, NK Cell Lectin-Like | 1 | 1999 | 30 | 0.010 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily D | 1 | 1999 | 30 | 0.010 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 1999 | 84 | 0.010 |
Why?
|
Patient Selection | 1 | 2011 | 4283 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 9276 | 0.010 |
Why?
|
Cell-Free System | 1 | 1999 | 341 | 0.010 |
Why?
|
Cell Communication | 1 | 2006 | 1653 | 0.010 |
Why?
|
Apoptosis | 1 | 1994 | 9501 | 0.010 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 1999 | 419 | 0.010 |
Why?
|
Gene Deletion | 1 | 2005 | 2668 | 0.010 |
Why?
|
Body Weight | 1 | 2008 | 4611 | 0.010 |
Why?
|
Vacuoles | 1 | 1997 | 229 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 10827 | 0.010 |
Why?
|
Vesicular Transport Proteins | 1 | 1999 | 374 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39261 | 0.010 |
Why?
|
Water-Electrolyte Balance | 1 | 1997 | 325 | 0.010 |
Why?
|
DNA, Fungal | 1 | 1997 | 275 | 0.010 |
Why?
|
Genes, Fungal | 1 | 1997 | 439 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2013 | 7475 | 0.010 |
Why?
|
Artificial Intelligence | 1 | 2010 | 2557 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 1999 | 2014 | 0.010 |
Why?
|
Cell Size | 1 | 1997 | 624 | 0.010 |
Why?
|
Fungal Proteins | 1 | 1999 | 911 | 0.010 |
Why?
|
Membrane Proteins | 2 | 2004 | 7850 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 1999 | 1204 | 0.010 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 1999 | 1135 | 0.010 |
Why?
|
Thymus Gland | 1 | 1999 | 1247 | 0.010 |
Why?
|
Fas Ligand Protein | 1 | 1994 | 215 | 0.010 |
Why?
|
Mitogens | 1 | 1994 | 230 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2010 | 16939 | 0.010 |
Why?
|
Chronic Disease | 1 | 2008 | 9287 | 0.010 |
Why?
|
Trifluoroacetic Acid | 1 | 1992 | 5 | 0.010 |
Why?
|
Mice, Nude | 1 | 1999 | 3607 | 0.010 |
Why?
|
Lethal Dose 50 | 1 | 1992 | 72 | 0.010 |
Why?
|
Acetaldehyde | 1 | 1992 | 39 | 0.010 |
Why?
|
Cytochrome P-450 CYP2E1 | 1 | 1992 | 35 | 0.010 |
Why?
|
Signal Transduction | 2 | 2012 | 23376 | 0.010 |
Why?
|
Biotransformation | 1 | 1992 | 166 | 0.010 |
Why?
|
Microsomes, Liver | 1 | 1992 | 173 | 0.010 |
Why?
|
CD40 Ligand | 1 | 1994 | 521 | 0.010 |
Why?
|
Oxidoreductases, N-Demethylating | 1 | 1992 | 110 | 0.010 |
Why?
|
Phenobarbital | 1 | 1992 | 189 | 0.010 |
Why?
|
Mitochondria, Liver | 1 | 1992 | 190 | 0.010 |
Why?
|
Fetus | 1 | 1999 | 1859 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 1992 | 532 | 0.010 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 1994 | 899 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 1999 | 4625 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2004 | 11071 | 0.010 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 1992 | 412 | 0.010 |
Why?
|
Interleukin-1 | 1 | 1994 | 1249 | 0.010 |
Why?
|
Cytosol | 1 | 1992 | 887 | 0.010 |
Why?
|
Interleukins | 1 | 1994 | 785 | 0.010 |
Why?
|
Disease Progression | 1 | 2006 | 13502 | 0.010 |
Why?
|
Infant | 1 | 2011 | 36060 | 0.010 |
Why?
|
Rats, Wistar | 1 | 1992 | 1850 | 0.000 |
Why?
|
NAD | 1 | 1992 | 609 | 0.000 |
Why?
|
Animals, Newborn | 1 | 1994 | 2672 | 0.000 |
Why?
|
Leukemia L1210 | 1 | 1987 | 44 | 0.000 |
Why?
|
Leukemia, Experimental | 1 | 1987 | 225 | 0.000 |
Why?
|
Ethanol | 1 | 1992 | 1323 | 0.000 |
Why?
|
Brain | 1 | 2013 | 26951 | 0.000 |
Why?
|
Up-Regulation | 1 | 1994 | 4122 | 0.000 |
Why?
|
Liver Diseases | 1 | 1992 | 1302 | 0.000 |
Why?
|
Cell Survival | 1 | 1994 | 5797 | 0.000 |
Why?
|
Child | 1 | 2011 | 79806 | 0.000 |
Why?
|
DNA, Neoplasm | 1 | 1987 | 1745 | 0.000 |
Why?
|
DNA Replication | 1 | 1987 | 1412 | 0.000 |
Why?
|
Aging | 1 | 1999 | 8651 | 0.000 |
Why?
|
Leukemia | 1 | 1987 | 1520 | 0.000 |
Why?
|
Cell Cycle | 1 | 1987 | 2934 | 0.000 |
Why?
|
Rats | 1 | 1992 | 23711 | 0.000 |
Why?
|
Breast Neoplasms | 1 | 1999 | 21025 | 0.000 |
Why?
|